Pyrazinecarboxylic acid - CAS 98-97-5
Catalog: |
BB042237 |
Product Name: |
Pyrazinecarboxylic acid |
CAS: |
98-97-5 |
Synonyms: |
pyrazine-2-carboxylic acid |
IUPAC Name: | pyrazine-2-carboxylic acid |
Description: | Pyrazinecarboxylic acid (CAS# 98-97-5) is used in the synthesis of neurokinin-2-receptor antagonists for treatment of various respiratory, gastrointestinal and CNS disease. |
Molecular Weight: | 124.10 |
Molecular Formula: | C5H4N2O2 |
Canonical SMILES: | C1=CN=C(C=N1)C(=O)O |
InChI: | InChI=1S/C5H4N2O2/c8-5(9)4-3-6-1-2-7-4/h1-3H,(H,8,9) |
InChI Key: | NIPZZXUFJPQHNH-UHFFFAOYSA-N |
Boiling Point: | 313.1 °C at 760 mmHg |
Purity: | 97.0 % |
Density: | 1.403 g/cm3 |
Appearance: | White solid |
MDL: | MFCD00006130 |
LogP: | 0.17480 |
GHS Hazard Statement: | H302 (33.33%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2016168100-A1 | Anti-hiv compounds | 20141215 |
US-2016096827-A1 | Tank-binding kinase inhibitor compounds | 20140926 |
WO-2015195950-A1 | Lmp7 inhibitors | 20140620 |
US-2015279654-A1 | Treating solution for electronic parts, and process for producing electronic parts | 20140329 |
US-2015273013-A1 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | 20140325 |
PMID | Publication Date | Title | Journal |
28425350 | 20180401 | Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid | Human & experimental toxicology |
27449999 | 20160701 | Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis | Tuberculosis (Edinburgh, Scotland) |
24333643 | 20140312 | Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences |
22372927 | 20120801 | A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis | Microbial drug resistance (Larchmont, N.Y.) |
22455352 | 20120701 | Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms | Clinical science (London, England : 1979) |
Complexity: | 116 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 124.027277375 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 124.027277375 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 63.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Pyrazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS